Particularly interesting considering the drug is repurposed...

Particularly interesting considering the drug is repurposed (IXC's Presendin, is AstraZeneca's Exenatide, of course different indications)

I havent read anything regarding tolerance for that indication, I guess we will find out in the longer term phase 3 if for the indication of IIH a tolerance-like effect is experienced in longer term use of Presendin for those concerned symptoms/endpoints.

Super interesting mate, thank you. If time permits, I and Im sure many others would love further insights surrounding what IXC are doing here.